MaxCyte is a global cell, gene and protein-based life sciences company helping to advance unmet medical needs. Nine of the top 10 global biopharmaceutical companies are developing next-generation therapeutics utilizing MaxCyte’s Flow Electroporation® Technology. MaxCyte’s more than 55 partnered program licenses includes in excess of 25 licensed for clinical use.
Find us at the event
- Stand number